DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Amneal Pharmaceuticals
03 1Cipla
04 1Epic Pharma. LLC.
05 1Novartis Pharmaceuticals Corporation
06 1Sandoz B2B
01 1EMULSION
02 5EMULSION;OPHTHALMIC
01 1Prescription
02 5RX
01 4DIFLUPREDNATE
02 2DUREZOL
01 1Canada
02 5USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUPREDNATE
Dosage Form : EMULSION;OPHTHALMIC
Dosage Strength : 0.05%
Packaging :
Approval Date : 2022-11-16
Application Number : 214894
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUPREDNATE
Dosage Form : EMULSION;OPHTHALMIC
Dosage Strength : 0.05%
Packaging :
Approval Date : 2021-11-17
Application Number : 211526
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUPREDNATE
Dosage Form : EMULSION;OPHTHALMIC
Dosage Strength : 0.05%
Packaging :
Approval Date : 2021-08-09
Application Number : 211776
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DIFLUPREDNATE
Dosage Form : EMULSION;OPHTHALMIC
Dosage Strength : 0.05%
Packaging :
Approval Date : 2024-05-14
Application Number : 207284
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DUREZOL
Dosage Form : EMULSION
Dosage Strength : 0.05%/W/V
Packaging : 5ML
Approval Date :
Application Number : 2415534
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : DUREZOL
Dosage Form : EMULSION;OPHTHALMIC
Dosage Strength : 0.05%
Packaging :
Approval Date : 2008-06-23
Application Number : 22212
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?